We have located links that may give you full text access.
Hip resurfacing in patients with severe osteoarthritis and blocked medullary canal.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy 2018 May 2
INTRODUCTION: This study evaluated the effectiveness of hip resurfacing in patients with femoral deformities or retained femoral implants. Implant removal and conversion total hip replacement (CTHR) have been associated with increased operative time, blood loss, and cost. Removing intramedullary nails in particular can be difficult and can result in a more difficult recovery and/or complications. Hip resurfacing can be performed with a blocked femoral canal and has the possible additional benefits of a less-complex procedure, improved functional outcomes, better patient survivorship, and a possibly less-complicated revision should a failure occur.
MATERIALS AND METHODS: The author performed hip resurfacing in 61 patients (65 hips) with a blocked femur who had been advised elsewhere that they could not undergo THR without also undergoing additional surgical procedures. The perioperative complexity of resurfacing was evaluated by recording operative time, blood loss and functional outcomes using the Harris Hip Score (HHS) and Short-Form 12 (SF-12) questionnaire. Implant survivorship was evaluated by the need for revision surgery.
RESULTS: At 9 years' mean follow-up (range 5-19 years), 59 of the 61 patients presented for postoperative evaluation. The mean operative time was 104 minutes and the mean blood loss was 300 cc. The mean HHS improved from 41 to 92 ( p < 0.001) and the mean SF-12 physical and mental scores improved from 26 to 49 and from 44 to 54, respectively ( p < 0.001). None of the procedures failed or required revision.
CONCLUSION: Canal-sparing hip resurfacing is a successful and less complicated option than CTHR when there is deformity or retained implant blocking the femoral canal.
MATERIALS AND METHODS: The author performed hip resurfacing in 61 patients (65 hips) with a blocked femur who had been advised elsewhere that they could not undergo THR without also undergoing additional surgical procedures. The perioperative complexity of resurfacing was evaluated by recording operative time, blood loss and functional outcomes using the Harris Hip Score (HHS) and Short-Form 12 (SF-12) questionnaire. Implant survivorship was evaluated by the need for revision surgery.
RESULTS: At 9 years' mean follow-up (range 5-19 years), 59 of the 61 patients presented for postoperative evaluation. The mean operative time was 104 minutes and the mean blood loss was 300 cc. The mean HHS improved from 41 to 92 ( p < 0.001) and the mean SF-12 physical and mental scores improved from 26 to 49 and from 44 to 54, respectively ( p < 0.001). None of the procedures failed or required revision.
CONCLUSION: Canal-sparing hip resurfacing is a successful and less complicated option than CTHR when there is deformity or retained implant blocking the femoral canal.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app